Does REGORAFENIB Cause Metastases to liver? 246 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 246 reports of Metastases to liver have been filed in association with REGORAFENIB (Stivarga). This represents 2.6% of all adverse event reports for REGORAFENIB.
246
Reports of Metastases to liver with REGORAFENIB
2.6%
of all REGORAFENIB reports
55
Deaths
56
Hospitalizations
How Dangerous Is Metastases to liver From REGORAFENIB?
Of the 246 reports, 55 (22.4%) resulted in death, 56 (22.8%) required hospitalization, and 3 (1.2%) were considered life-threatening.
Is Metastases to liver Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REGORAFENIB. However, 246 reports have been filed with the FAERS database.
What Other Side Effects Does REGORAFENIB Cause?
Off label use (1,906)
Fatigue (1,530)
Palmar-plantar erythrodysaesthesia syndrome (1,230)
Diarrhoea (1,221)
Decreased appetite (941)
Asthenia (825)
Death (813)
Dysphonia (702)
Nausea (688)
Pain in extremity (686)
What Other Drugs Cause Metastases to liver?
LETROZOLE (1,295)
FULVESTRANT (1,241)
CAPECITABINE (1,061)
EVEROLIMUS (1,020)
RIBOCICLIB (967)
PACLITAXEL (885)
OCTREOTIDE (774)
BEVACIZUMAB (707)
FLUOROURACIL (630)
TAMOXIFEN (595)
Which REGORAFENIB Alternatives Have Lower Metastases to liver Risk?
REGORAFENIB vs REGORAFENIB\REGORAFENIB
REGORAFENIB vs RELATLIMAB
REGORAFENIB vs RELPAX
REGORAFENIB vs RELUGOLIX
REGORAFENIB vs REMDESIVIR